对动脉样硬化中的泡细胞的新见解
Jian Ai1,2, Xin Tang1,2, Yongkang Zhou1,2
1State Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu 214122, China.
Cardiovascular research
|October 27, 2025
概括
泡细胞通过积累胆固醇来驱动动动脉硬化,导致斑块不稳定. 准这些泡细胞为开发精密疗法来治疗和预防心血管事件提供了一个有希望的战略.
科学领域:
- 心血管科学 心血管科学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是心血管事件的主要原因,其特点是动脉中含有胆固醇的泡细胞积累.
- 泡细胞扩张促进了亡和亡,有助于死核形成和斑块不稳定.
研究的目的:
- 提供泡细胞起源及其在动脉样硬化中的致病作用的全面概述.
- 探索泡细胞与动脉样硬化的残留风险之间的相互作用.
- 研究针对泡细胞的潜在治疗干预措施.
主要方法:
- 文献综述专注于泡细胞生物学和动脉样硬化.
- 对现有的临床药物和天然产品进行分析,以检测它们对泡细胞的类作用.
- 泡细胞切除策略的综合.
主要成果:
- 泡细胞是动脉动脉生成和斑块脆弱性的核心.
- 泡细胞和其他危险因素之间的相互作用会加剧动脉样硬化.
- 临床药物和天然产品显示出泡细胞向干预的潜力.
结论:
- 向泡细胞是治疗和预防动脉样硬化的可行策略.
- 对泡细胞切除的进一步研究可以导致精密疗法.
- 了解泡细胞交叉交谈对于管理残留心血管风险至关重要.
相关概念视频
Inflammation
61.6K
Overview
61.6K
Atherosclerosis I: Introduction
890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
Peripheral Artery Disease I: Introduction
302
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
302
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
455
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
455


